Valley Cottage, New York, Oct. 23, 2017 -- Unhealthy gain in weight is a rising epidemic observed across the globe. This is mainly caused owing to improper eating habits, wrong time of eating, less or no exercise, health ignorance owing to increased reliance on medications, etc. However, along with this rising epidemic, there is an increase in the awareness among people to look healthy and slim. This has triggered the emergence of techniques and procedures for fat loss. The advent of technology has given rise and popularity to non-invasive or non-surgical procedures for fat removal. Under proper medication, care and guidance, these non-surgical procedures deliver high benefits in terms of efficiency, quick results and convenience. These aspects along with less procedure time and less complications are driving the growth of the global non-surgical fat reduction market. However, higher costs associated with this technique coupled with hidden procedural costs pose a challenge to the growth of the global market.
Global Market Research Report Overview on Non-Surgical Fat Reduction @ https://www.futuremarketinsights.com/reports/non-surgical-fat-reduction-market
The comprehensive research study on “Non-Surgical Fat Reduction Market: Global Industry Analysis (2012-2016) and opportunity Assessment (2017-2022)” skilfully analysed and crafted by Future Market Insights delivers the much needed value addition to the reader with the help of which expansion strategies can be devised to obtain competitive advantage. According to this study, the global non-surgical fat reduction market is projected to grow at significant CAGR of 5.1% throughout the assessment period, 2017-2022.
3 Key Projections on Global Non-Surgical Fat Reduction Market
By Product type, the laser based devices segment is expected to be the largest segment in terms of value and market share. Moreover, this segment is projected to grow at the highest pace to register a CAGR of 5.6% throughout the period of assessment
View Report Table of Contents, Figures, and Tables@ https://www.futuremarketinsights.com/reports/non-surgical-fat-reduction-market/toc
By End user type, the beauty clinics segment is expected to show high demand for non-surgical fat reduction treatments. This segment is expected to comparatively grow at a high rate during the 2017-2022 period. The dermatology clinics segment shows a high adoption of non-surgical fat reduction procedures. This segment is likely to dominate the global market in the years to come
By Region, North America is expected to be highly attractive for the growth of the global non-surgical fat reduction market. This region is highly lucrative for the market growth owing to high technology advancements, high disposable income of people and increasing number of key players dealing with non-surgical fat reduction devices in this region
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5321
Competitive Scenario in the Global Non-Surgical Fat Reduction Market
The non-surgical fat reduction market research study includes a detailed profiling of key players operating in this market. Company overview, key financials, SWOT analysis and developments and key innovations of the tier players is studied during the course of the research and depicted in this study. Tier players like Cutera Inc., Lutronic Corporation, Syneron Medical Ltd., Cynosure, Inc., Fotona d.d., Solta Medical Inc., Venus Concept Canada Corp., Lynton Lasers Ltd., Alma Lasers, Ltd., EL.En. S.p.A., and Sciton, Inc., are profiled in this research.
616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: [email protected] Website: http://www.futuremarketinsights.com


Bain Capital Moves to Acquire Majority Stake in Echo Marketing
NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up 



